Casticin also prevented cadherin switching from taking place and aided cells in maintaining their normal migratory behavior in a mouse CD133+ cell line against hepatocellular carcinoma by upregulating E-cadherin and decreasing N-cadherin levels [79]. Here, CDH2 is linked to hepatocellular carcinoma.